Question

A 60-year-old with newly diagnosed HFrEF (EF 30%) is on maximally tolerated ACE inhibitor, evidence-based beta-blocker, and MRA. He is euvolemic. Which next therapy reduces CV death and HF hospitalization?

Accepted Answer

SGLT2 inhibitor

Answer

Ivabradine

Answer

Hydralazine alone

Answer

Vericiguat

Answer

Long-acting nitrate

Practice question

A 60-year-old with newly diagnosed HFrEF (EF 30%) is on maximally tolerated ACE inhibitor, evidence-based beta-blocker, and MRA. He is euvolemic. Which next therapy reduces CV death and HF hospitalization?